title: Preparation and optimization of chitosan nanoparticles and magnetic chitosan nanoparticles as delivery systems using Box-Behnken statistical design.
abstract: Chitosan nanoparticles and magnetic chitosan nanoparticles can be applied as delivery systems for the anti-Alzheimer drug tacrine. Investigation was carried out to elucidate the influence of process parameters on the mean particle size of chitosan nanoparticles produced by spontaneous emulsification. The method was optimized using design of experiments (DOE) by employing a 3-factor, 3-level Box-Behnken statistical design. This statistical design is used in order to achieve the minimum size and suitable morphology of nanoparticles. Also, magnetic chitosan nanoparticles were synthesized according to optimal method. The designed nanoparticles have average particle size from 33.64 to 74.87nm, which were determined by field emission scanning electron microscopy (FE-SEM). Drug loading in the nanoparticles as drug delivery systems has been done according to the presented optimal method and appropriate capacity of drug loading was shown by ultraviolet spectrophotometry. Chitosan and magnetic chitosan nanoparticles as drug delivery systems were characterized by Diffuse Reflectance Fourier Transform Mid Infrared spectroscopy (DR-FTMIR).
authors.affiliation: Department of Chemistry, Faculty of Science, IKIU, Qazvin, Iran. k.elmizadeh@yahoo.com
authors.forename: Hamideh
authors.initials: H
authors.lastname: Elmizadeh
authors.forename: Mohammadreza
authors.initials: M
authors.lastname: Khanmohammadi
authors.forename: Keyvan
authors.initials: K
authors.lastname: Ghasemi
authors.forename: Gholamreza
authors.initials: G
authors.lastname: Hassanzadeh
authors.forename: Marjan
authors.initials: M
authors.lastname: Nassiri-Asl
authors.forename: Amir Bagheri
authors.initials: AB
authors.lastname: Garmarudi
mesh_terms: D048271:Chitosan / Q000737:chemistry*; D004339:Drug Compounding; D016503:Drug Delivery Systems; D004655:Emulsions; D058185:Magnetite Nanoparticles; D008855:Microscopy, Electron, Scanning; D053758:Nanoparticles; D018697:Nootropic Agents / Q000008:administration & dosage; D010316:Particle Size; D017550:Spectroscopy, Fourier Transform Infrared / Q000379:methods; D013619:Tacrine / Q000008:administration & dosage*
chemical_list: D004655:Emulsions; D058185:Magnetite Nanoparticles; D018697:Nootropic Agents; D013619:Tacrine; D048271:Chitosan